CPSAC
GILD icon

Chas P. Smith & Associates (CPS)’s Gilead Sciences GILD Stock Holding History

Chas P. Smith & Associates (CPS)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,019
Closed -$245K – 101
2017
Q3 		$245K Sell
3,019
-71
-2% -$5.43K 0.04% 86
2017
Q2 		$219K Sell
3,090
-1,772
-36% -$118K 0.03% 89
2017
Q1 		$330K Sell
4,862
-126,725
-96% -$8.91M 0.05% 77
2016
Q4 		$9.42M Sell
131,587
-49,407
-27% -$3.67M 1.5% 29
2016
Q3 		$14.3M Buy
180,994
+1,494
+0.8% +$121K 2.37% 23
2016
Q2 		$15M Buy
179,500
+1,783
+1% +$158K 2.52% 21
2016
Q1 		$16.3M Sell
177,717
-1,549
-0.9% -$140K 2.79% 16
2015
Q4 		$18.1M Buy
179,266
+1,813
+1% +$189K 3.2% 9
2015
Q3 		$17.4M Buy
177,453
+4,070
+2% +$452K 3.35% 8
2015
Q2 		$20.3M Buy
173,383
+9,740
+6% +$1.06M 3.56% 7
2015
Q1 		$16.1M Buy
163,643
+3,339
+2% +$339K 2.88% 12
2014
Q4 		$15.1M Buy
160,304
+11,419
+8% +$1.18M 2.74% 15
2014
Q3 		$15.8M Buy
148,885
+70,747
+91% +$6.93M 3.15% 10
2014
Q2 		$6.48M Buy
+78,138
New +$6.08M 1.32% 35

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Chas P. Smith & Associates (CPS)'s GILD Position: Q4 2017 in Review

Chas P. Smith & Associates (CPS) sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 3,019 shares — an estimated $245K sold.

Chas P. Smith & Associates (CPS) first reported a position in GILD in Q2 2014 and held it in 14 quarters. The position peaked at $20.3M in Q2 2015. 1,576 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • Chas P. Smith & Associates (CPS) reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
  • Chas P. Smith & Associates (CPS) sold 3,019 Gilead Sciences shares in Q4 2017, an estimated $245K.
  • Chas P. Smith & Associates (CPS) first reported a position in Gilead Sciences in Q2 2014 and held it in 14 quarters.
  • Chas P. Smith & Associates (CPS)'s Gilead Sciences position peaked at $20.3M in Q2 2015.
  • 1,576 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on Chas P. Smith & Associates (CPS)'s 13F filing for Q4 2017, filed 9 Feb 2018.